Tirzepatide for hypertension

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 23 Jan 2026: Trial registered, NCT07364175

The trials

NCT07364175: A Trial Within Cohort Feasibility Study Design Comparing Standard of Care Versus Weight Loss (Achieved Through Tirzepatide) for Obesity-related Hypertension in Young Adults

State
Under way
Phase
No phase
People
60 planned
Started
Jan 2026
Primary completion
Jan 2027
Arms
Tirzepatide [weight loss arm]
Results
None posted
  1. 23 Jan 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Also known as Arm 5- Tirzepatide, Mounjaro, Tirzepatide (LIPOLESS de Laboratorio de Productos Eticos C.E.I.S.A.), Zepbound.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.